Aravind Palraj / X
Jul 22, 2025, 09:17
Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
Aravind Palraj, MD highlights a crucial message on his X page:
”Antiphospholipid antibodies (aPL) are key to diagnosing APS—but timing, type, and persistence matter.
Triple positive? Highest thrombosis risk.
Test smart. Interpret wisely.”
Want to dive deeper into Antiphospholipid Syndrome?
On Hemostasis Today, you can explore in-depth, clinically relevant, and first-hand academic knowledge on:
- Diagnostic strategies for APS
- Role of Lupus Anticoagulant, anticardiolipin, and β2-GPI antibodies
- Risk stratification and management approaches in triple-positive patients
- Anticoagulation dilemmas in APS
-
Mar 13, 2026, 12:18Abdallah Othman: Arterial Blood Supply of the Cardiac Conduction System
-
Mar 13, 2026, 12:14Roshni Kulkarni: Honoring Women and Girls Living With Bleeding Disorders
-
Mar 13, 2026, 11:48Kausik Ray: Efficacy and Safety of Obicetrapib in Patients With HeFH on Maximally Tolerated Statins
-
Mar 13, 2026, 11:36Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis
-
Mar 13, 2026, 10:28Anupama Ariyasiri։ A Systematic Review of Transfusion Strategies in Neurocritical Care
-
Mar 13, 2026, 10:08Jack Hadfield: An Important Step Toward Finding Measurable Biology in Long COVID
-
Mar 13, 2026, 10:00Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?